Extreme obesity with alveolar hypoventilation

E4_OBESITYXTRMALV

obesity: A disorder involving an excessive amount of body fat.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E66.2 Hospital discharge: ICD-9 — 2788A Cause of death: ICD-10 — E66.2 Cause of death: ICD-9 — 2788A 2 out of 7 registries used, show all original rules.	1565
4. Check minimum number of events None	1565
5. Include endpoints None	1565
6. Filter based on genotype QC (FinnGen only)	1519

Control definitions (FinnGen only)

Control exclude: E4_OBESITY

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E66
Name in latin: Obesitas extrema cum hypoventilatione alveolari

NAME	E4_OBESITYXTRMALV
CONTROL_EXCLUDE	E4_OBESITY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E662
HD_ICD_9	2788A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E662
COD_ICD_9	2788A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Extreme obesity with alveolar hypoventilation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	9083	4806	4240
Only index persons	8456	4518	3938
Unadjusted period prevalence (%)
Whole population	0.13	0.14	0.12
Only index persons	0.16	0.17	0.15
Median age at first event (years)
Whole population	62.01	62.99	60.88
Only index persons	62.08	62.87	61.17

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1519	855	664
Unadjusted period prevalence (%)	0.30	0.30	0.30
Median age at first event (years)	59.86	58.64	61.42

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1565: Matched controls
15650

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WX725

NOMESCO Finland

Noninvasive ventilation

11.1

312.3

377

436

103

Kela drug reimbursment

Diabetes, insulin-treated

6.6

309.4

883

2570

XG466

NOMESCO Finland

Sleep oxymetry

23.6

307.7

316

166

C03CA01

ATC

furosemide; systemic

11.5

307.7

1099

2657

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

21.5

307.7

393

240

I50.9

ICD-10 Finland

Heart failure, unspecified

10.9

307.7

651

959

E66.9

ICD-10 Finland

Obesity, unspecified

150.7

307.7

428

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

14.1

307.7

376

343

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

+∞

307.7

1564

E66

ICD-10 Finland

Obesity

20.4

307.7

384

246

E66.01

ICD-10 Finland

Obesity due to excess calories

93.6

307.7

837

190

E66.00

ICD-10 Finland

Metabolic syndrome

61.5

307.7

532

130

A10BA02

ATC

metformin; oral

7.6

307.7

968

2744

T82

ICPC

Obesity

28.6

307.7

371

168

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

14.2

307.7

404

374

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

8.1

307.7

886

2179

E66.8

ICD-10 Finland

Other obesity

275.0

307.7

647

J96.1

ICD-10 Finland

Chronic respiratory failure

72.0

307.7

492

G47.3

ICD-10 Finland

Sleep apnoea

17.5

307.7

1163

2216

R5140

NOMESCO Finland

Monitoring the use of the aid

12.0

307.7

659

895

A46

ICD-10 Finland

Erysipelas

7.4

306.4

600

1218

I50.0

ICD-10 Finland

Congestive heart failure

10.8

297.2

364

428

T90

ICPC

Diabetes non-insulin dependent

6.0

275.3

797

2304

A10BJ02

ATC

liraglutide; parenteral

20.4

272.4

216

122

215

Kela drug reimbursment

Diabetes, non-insulin-treated

5.8

261.6

798

2395

A10BJ06

ATC

semaglutide; parenteral

11.7

259.4

290

298

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

7.7

257.2

433

739

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

7.4

253.2

449

809

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

39.0

245.5

152

160

Kela drug reimbursment

exenatide

23.8

244.8

180

R06.0

ICD-10 Finland

Dyspnoea

5.3

235.0

820

2705

J96.0

ICD-10 Finland

Acute respiratory failure

29.3

220.4

149

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

+∞

211.4

198

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

40.1

210.3

129

C03DA01

ATC

spironolactone; oral

6.1

208.5

447

958

SPAT1262

SPAT

Handing over of treatment supplies

5.3

208.4

582

1575

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

5.8

206.8

485

1128

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

9.7

205.5

261

316

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.8

203.0

719

2349

R03BB04

ATC

tiotropium bromide; inhalant

6.1

195.7

410

856

A10AE04

ATC

insulin glargine; parenteral

6.4

192.6

376

733

WX722

NOMESCO Finland

PEEP

9.6

189.2

241

292

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

8.9

181.8

246

321

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

5.4

179.3

447

1085

A10BX07

ATC

[U] liraglutide

26.6

179.1

125

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.9

177.5

511

1397

SPAT1148

SPAT

Treatment of chronic ulcer or burn

5.2

173.8

446

1107

J45.9

ICD-10 Finland

Asthma, unspecified

4.6

169.4

565

1726

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

11.0

168.2

190

195

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.7

167.7

528

1542

S97

ICPC

Chronic ulcer skin

7.3

165.9

270

434

M04AA01

ATC

allopurinol; systemic

5.1

158.8

418

1053

J96.9

ICD-10 Finland

Respiratory failure, unspecified

46.5

156.0

A08AB01

ATC

orlistat; oral

57.5

154.2

162

Kela drug reimbursment

liraglutide

25.2

149.4

106

R03AC02

ATC

salbutamol; inhalant

4.4

146.9

1183

6489

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.3

144.7

494

1514

205

Kela drug reimbursment

Chronic hypertension

3.8

144.4

672

2559

I10

ICD-10 Finland

Essential (primary) hypertension

4.8

141.7

1277

7494

A10AB05

ATC

insulin aspart; parenteral

6.1

141.3

277

534

R03AK06

ATC

salmeterol and fluticasone; inhalant

4.4

138.6

436

1253

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.6

138.2

413

1141

I50

ICD-10 Finland

Heart failure

11.7

137.8

147

138

R60.0

ICD-10 Finland

Localized oedema

4.7

136.8

386

1019

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

7.8

132.2

195

279

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

131.0

1021

5317

OAB72

NOMESCO Finland

Weight control and weight loss guidance

52.5

130.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

5.5

127.2

277

586

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.6

125.2

644

2574

A10BH01

ATC

sitagliptin; oral

5.0

124.9

313

747

E66.0

ICD-10 Finland

Obesity due to excess calories

1274.1

122.6

118

R02

ICPC

Shortness of breath/dyspnoea

4.3

120.4

385

1110

H02AB06

ATC

prednisolone; systemic

3.4

118.9

1019

5503

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.6

114.9

507

1821

L28

ICPC

Limited function/disability (L)

3.8

114.1

460

1556

B03BA03

ATC

hydroxocobalamin; parenteral

6.3

112.2

203

359

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

10.5

112.1

128

132

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.3

110.6

346

977

A10BB12

ATC

glimepiride; oral

5.7

110.5

228

457

A10BK03

ATC

empagliflozin; oral

4.5

109.9

316

837

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.6

108.9

303

782

J01FF01

ATC

clindamycin; systemic

3.3

108.5

653

2825

SPAT1254

SPAT

Administration of medicine

4.0

107.3

375

1145

N05AA02

ATC

levomepromazine; systemic

7.0

105.0

170

268

A10BX04

ATC

[U] exenatide

21.3

104.4

SPAT1229

SPAT

Assessment of need for aid

5.0

100.3

243

559

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.7

99.8

391

1286

C07AB07

ATC

bisoprolol; oral

3.0

97.0

992

5674

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

5.0

96.9

233

532

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.7

96.9

163

267

J01MA12

ATC

levofloxacin; systemic

3.3

94.6

469

1785

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

8.3

93.3

127

164

N05AF03

ATC

chlorprothixene; systemic

9.0

92.3

118

141

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

9.8

92.3

110

120

A10BJ05

ATC

dulaglutide; parenteral

10.9

92.1

101

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

7.7

89.1

130

182

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.2

88.8

454

1752

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

7.4

88.8

135

198

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

7.4

88.8

134

195

N05AX12

ATC

aripiprazole; systemic

7.2

88.5

137

205

A10AC01

ATC

insulin (human); parenteral

4.8

87.6

221

523

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.4

86.8

402

1459

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.2

86.0

191

406

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

6.9

85.9

139

218

A28

ICPC

Limited function/disability NOS

3.3

85.7

405

1487

R06.2

ICD-10 Finland

Wheezing

6.1

85.5

157

280

M10.9

ICD-10 Finland

Gout, unspecified

4.8

85.1

214

505

B01AA03

ATC

warfarin; systemic

3.2

84.3

422

1603

J46

ICD-10 Finland

Status asthmaticus

8.1

82.3

114

150

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.6

80.2

313

1015

A10AE05

ATC

insulin detemir; parenteral

5.3

80.2

172

354

WX723

NOMESCO Finland

CPAP therapy

5.7

78.6

156

299

J01CE08

ATC

benzathine benzylpenicillin; parenteral

17.3

78.4

N02AX02

ATC

tramadol; systemic, rectal

2.6

77.0

866

4987

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

6.5

76.7

131

217

N05AH04

ATC

quetiapine; oral

3.1

76.4

405

1581

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

3.2

75.6

367

1360

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

74.1

627

3129

N06AX16

ATC

venlafaxine; oral

3.2

73.8

353

1295

SPAT1263

SPAT

Sampling

2.6

71.4

799

4537

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.4

70.9

294

986

A10BK01

ATC

dapagliflozin; oral

4.3

70.4

202

526

A08

ICPC

Swelling

4.9

70.3

164

362

R60.9

ICD-10 Finland

Oedema, unspecified

4.9

70.1

165

367

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

3.3

69.9

318

1129

A10BH05

ATC

linagliptin; oral

5.1

69.3

156

334

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

4.1

69.1

211

575

J45.1

ICD-10 Finland

Nonallergic asthma

4.2

68.4

201

532

A41.9

ICD-10 Finland

Sepsis, unspecified

6.0

68.3

126

225

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.8

68.2

163

367

GX2C5

NOMESCO Finland

Short-lasting oximetry

22.4

67.8

RK320, ,

NOMESCO Finland

19.6

67.7

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.8

66.7

446

1959

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.5

66.3

677

3652

S76

ICPC

Skin infection other

4.7

66.1

162

372

WX730

NOMESCO Finland

Conventional respirator

10.1

65.8

K77

ICPC

Heart failure

9.3

65.4

TPH07

NOMESCO Finland

Cathetrisation of artery

3.3

64.9

288

1004

358

Kela drug reimbursment

liraglutide

21.0

64.7

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

64.7

506

2400

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.0

64.5

344

1335

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.9

64.0

205

577

A10BJ01

ATC

exenatide; parenteral

13.5

63.3

SPAT1301

SPAT

No procedures

2.5

63.3

611

3195

N02AA05

ATC

oxycodone; systemic

2.8

63.3

389

1630

J01DB01

ATC

cefalexin; oral

4.1

63.1

1423

11111

WX780

NOMESCO Finland

Remote monitoring CPAP

5.0

63.0

145

316

N03AX16

ATC

[U] pregabalin

2.6

62.7

508

2445

C09AA02

ATC

enalapril; systemic

2.8

62.4

417

1823

A10BH02

ATC

vildagliptin; oral

8.9

62.3

N05AX08

ATC

risperidone; systemic

3.8

62.2

207

598

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.3

61.2

266

914

A06AD11

ATC

lactulose; oral

3.0

60.7

319

1224

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

11.7

60.7

SPAT1255

SPAT

Intravenous administration of medicine

3.9

60.0

192

539

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.7

59.6

148

343

B01AB05

ATC

enoxaparin; parenteral

2.4

59.3

627

3395

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

8.1

58.7

103

N06AX12

ATC

bupropion; oral

4.2

58.5

167

431

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

3.2

57.9

269

960

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

4.9

56.9

132

289

N05AH03

ATC

olanzapine; systemic

4.0

56.6

175

479

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

16.5

56.6

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.4

56.3

561

2946

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.5

56.2

214

675

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

11.1

56.0

C08CA01

ATC

amlodipine; oral

2.3

55.9

730

4301

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.0

55.8

170

460

J45.8

ICD-10 Finland

Mixed asthma

5.9

55.7

103

184

J45

ICD-10 Finland

Asthma

3.3

55.6

242

829

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

55.5

N03AX09

ATC

lamotrigine; oral

4.8

55.0

131

293

N05AB03

ATC

perphenazine; systemic, rectal

5.2

54.9

117

238

QBJ30

NOMESCO Finland

Correction of abdominal apron

79.4

54.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.1

54.0

264

968

C03AA03

ATC

hydrochlorothiazide; oral

3.4

53.7

218

715

R03DA04

ATC

theophylline; systemic, rectal

4.5

53.5

137

325

SPAT1260

SPAT

Consultation of another employee

2.7

53.3

371

1642

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.3

53.0

147

371

A12BA01

ATC

potassium chloride; oral

5.2

52.8

112

227

GX2D5

NOMESCO Finland

Sleep oximetry

18.7

52.7

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

6.9

52.6

126

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

+∞

52.4

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.4

52.3

138

335

R03AK08

ATC

formoterol and beclometasone; inhalant

4.5

51.9

135

324

N06AX21

ATC

duloxetine; oral

3.0

51.9

273

1042

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

7.0

51.7

119

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

8.0

50.9

SPAT1249

SPAT

Treatment-related counselling outside office

2.2

50.2

709

4262

SPAT1310

SPAT

Counselling related to known health issue

2.3

50.0

583

3242

C09AA05

ATC

ramipril; oral

2.3

49.5

494

2570

B81

ICPC

Anaemia vit B12/folate deficiency

5.0

49.2

109

229

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

+∞

49.2

XG410

NOMESCO Finland

Flow-volume spirometry

4.7

49.0

117

262

A10BG03

ATC

pioglitazone; oral

6.2

48.9

146

H3600, E113,

ICD-10 Finland

12.7

48.8

R03BA05

ATC

fluticasone; inhalant

2.5

48.5

369

1696

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.3

48.4

206

694

L17

ICPC

Foot/toe symptom/complaint

2.3

48.4

550

3018

SPAT1139

SPAT

Nutrition survey

5.1

48.1

105

218

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.2

48.0

824

5319

SPAT1305

SPAT

Counselling and guidance related to physical exercise

3.2

47.8

210

721

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.2

47.4

551

3045

E0000UV, ,

ATC

2.2

47.2

735

4559

K07

ICPC

Swollen ankles/oedema

4.3

47.2

128

317

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.0

47.1

104

218

OAB50, ,

SPAT

3.8

47.0

151

423

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.1

47.0

746

4661

N06AB04

ATC

citalopram; systemic

2.4

46.9

409

1998

B01AF02

ATC

apixaban; oral

2.8

46.8

268

1067

R03AK07

ATC

formoterol and budesonide; inhalant

2.4

46.8

418

2064

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

6.0

46.6

146

WX892

NOMESCO Finland

Monitored bed care

3.3

46.6

190

623

RD210, ,

NOMESCO Finland

9.8

46.2

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.7

46.1

303

1295

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

4.3

46.0

123

301

N06AA09

ATC

amitriptyline; systemic

3.0

45.7

230

853

SPAT1211

SPAT

Application of soft bandage

3.2

45.6

200

685

R95

ICPC

Chron obstructive pulmonary disease

5.3

45.4

190

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.6

45.3

113

262

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.7

45.3

278

1147

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

4.3

45.2

123

305

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.5

45.2

116

275

N06AB03

ATC

fluoxetine; oral

2.8

45.1

272

1112

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

3.6

44.9

163

496

SPAT1234

SPAT

Support of social functional capacity

4.2

44.8

127

325

C01AA05

ATC

digoxin; systemic

3.6

44.4

160

484

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.3

44.2

436

2240

R03AK03

ATC

[U] fenoterol and ipratropium bromide

4.3

44.1

121

302

SPAT1240

SPAT

Therapeutic discussion

3.1

44.0

209

750

A10AD05

ATC

insulin aspart; parenteral

7.7

43.9

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

6.2

43.5

128

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.7

43.3

263

1077

A02BC02

ATC

pantoprazole; systemic

2.3

43.1

1170

8852

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.9

43.1

225

850

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.1

43.1

123

316

SPAT1281

SPAT

Other administrative function

3.2

42.9

182

610

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

6.1

42.8

130

TKC20

NOMESCO Finland

Catheterisation of bladder

3.5

42.8

161

501

C09BA02

ATC

enalapril and diuretics; systemic

3.2

42.5

183

619

ZXD05

NOMESCO Finland

Urgent procedure

2.2

42.3

548

3134

M79.6

ICD-10 Finland

Pain in limb

2.1

42.3

749

4816

SPAT1312

SPAT

General health counselling

2.1

42.2

548

3137

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.4

42.2

168

542

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

4.6

42.1

105

243

C10AA01

ATC

simvastatin; oral

2.1

42.1

735

4700

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.5

42.1

319

1455

D64.9

ICD-10 Finland

Anaemia, unspecified

2.9

41.9

219

828

207

Kela drug reimbursment

Chronic arrhythmias

2.5

41.5

305

1370

N03AG01

ATC

valproic acid; systemic, rectal

3.6

41.3

148

446

201

Kela drug reimbursment

Chronic cardiac insufficiency

4.1

41.1

119

309

N05CD07

ATC

temazepam; oral

2.7

40.9

244

989

L30.4

ICD-10 Finland

Erythema intertrigo

8.1

40.6

R50.9

ICD-10 Finland

Fever, unspecified

2.5

40.4

295

1320

N05BA04

ATC

oxazepam; oral

2.2

40.4

476

2616

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.5

40.3

290

1289

A08AA02

ATC

fenfluramine; oral

10.1

40.2

R03BA01

ATC

beclometasone; inhalant

2.6

40.2

284

1251

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

5.3

39.9

161

Z02.7

ICD-10 Finland

Issue of medical certificate

3.4

39.7

152

478

N18.8

ICD-10 Finland

Other chronic renal failure

6.0

39.5

123

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.8

39.5

130

EBA15

NOMESCO Finland

Extraction of multiple teeth

4.2

39.4

108

269

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.3

39.4

163

R03DC03

ATC

montelukast; oral

2.4

39.4

323

1523

M10

ICD-10 Finland

Gout

4.0

39.0

114

298

SPAT1104

SPAT

Monitoring of emergency patient

3.3

38.9

154

494

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

3.7

38.6

128

366

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.7

38.5

133

E000001, ,

ATC

2.3

38.5

360

1795

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.4

38.4

149

472

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

38.3

263

1141

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

37.8

315

1493

K08.3

ICD-10 Finland

Retained dental root

3.0

37.6

179

641

JN3AD

NOMESCO Finland

Abdominal CT examination

2.7

37.5

237

986

J01DA01

ATC

[U] cefalexin

2.0

37.3

1038

7702

N02BE01

ATC

paracetamol; systemic, rectal

3.5

37.2

1462

12530

SPAT1231

SPAT

Assessment of adjustments needed in living environment

6.3

37.1

103

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.5

37.0

138

N05BA01

ATC

diazepam; systemic, rectal

2.5

36.6

271

1216

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.5

36.6

136

S18

ICPC

Laceration/cut

2.0

36.4

797

5426

C08CA13

ATC

lercanidipine; oral

2.4

36.3

292

1361

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.0

36.3

106

277

A10BG02

ATC

rosiglitazone; oral

7.2

36.2

F34.1

ICD-10 Finland

Dysthymia

4.3

36.2

242

RK110, ,

NOMESCO Finland

12.8

35.9

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.9

35.3

167

N04AA02

ATC

biperiden; systemic

6.1

35.3

105

A10AB06

ATC

insulin glulisine; parenteral

9.2

35.2

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.0

35.1

169

608

A10BB01

ATC

glibenclamide; oral

4.7

34.8

181

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

8.3

34.7

J01MA14

ATC

moxifloxacin; systemic

2.8

34.7

198

781

SPAT1172

SPAT

Guidance concerning hydration

6.1

34.4

101

3051, ,

Kela drug reimbursment

10.5

34.3

N05BA06

ATC

lorazepam; systemic, sublingual

3.5

34.3

124

375

N05AH02

ATC

clozapine; systemic

5.9

34.3

108

N05AD01

ATC

haloperidol; systemic

4.8

34.1

168

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

34.1

407

2226

P29

ICPC

Psychological sympt/compl other

3.3

33.9

134

429

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

5.8

33.8

113

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.0

33.8

163

587

SPAT1094

SPAT

Continuous Positive Airway Pressure

7.8

33.7

SPAT1243

SPAT

Psychiatric/psychological examination

5.7

33.7

117

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

33.5

869

6194

M54.5

ICD-10 Finland

Low back pain

1.9

33.5

622

3976

I50.1

ICD-10 Finland

Left ventricular failure

3.7

33.5

111

317

P76

ICPC

Depressive disorder

3.3

33.4

131

417

N06AB06

ATC

sertraline; oral

2.6

33.3

221

939

A10BD07

ATC

metformin and sitagliptin; systemic

3.7

33.2

108

304

N05AN01

ATC

lithium; oral

5.3

33.2

133

C02AC05

ATC

moxonidine; oral

3.6

33.2

114

333

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.4

33.2

201

T83

ICPC

Overweight

6.1

33.1

N03AE01

ATC

clonazepam; systemic

3.2

32.8

135

443

R06.5

ICD-10 Finland

Mouth breathing

2.7

32.7

193

774

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

32.3

529

3233

N19

ICD-10 Finland

Unspecified kidney failure

4.2

32.1

215

WX781

NOMESCO Finland

Remote monitoring, noninvasive ventilation

323.4

32.0

EBA00

NOMESCO Finland

Extraction of tooth

1.9

31.8

599

3830

R53

ICD-10 Finland

Malaise and fatigue

2.1

31.7

409

2295

OAB72, ,

SPAT

9.7

31.6

R4190

NOMESCO Finland

Nutritional therapy

4.2

31.4

214

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.2

31.3

129

U04

ICPC

Incontinence urine

3.3

31.1

121

383

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.8

31.0

101

R03BA02

ATC

budesonide; inhalant

2.2

30.9

325

1685

F61.0

ICD-10 Finland

Mixed personality disorders

6.6

30.8

D01AC02

ATC

miconazole; topical

2.8

30.7

165

629

K04.0

ICD-10 Finland

Pulpitis

2.6

30.5

188

769

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

5.6

30.5

106

XCK10

NOMESCO Finland

Photography of fundus of eye

2.6

30.3

192

797

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.0

30.2

138

481

TLC00

NOMESCO Finland

Insertion of intrauterine device

3.4

30.1

115

360

N06AX03

ATC

mianserin; oral

3.4

30.1

113

350

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

12.2

29.9

S10

ICPC

Boil/carbuncle

3.1

29.9

132

451

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.4

29.8

112

AA1AD

NOMESCO Finland

CT of head and brain

1.9

29.8

474

2854

C07AB02

ATC

metoprolol; systemic

2.1

29.6

346

1865

N05CF01

ATC

zopiclone; oral

1.9

29.5

555

3527

N06AB10

ATC

escitalopram; oral

2.1

29.5

342

1839

N03AX12

ATC

[U] gabapentin; oral

2.1

29.4

316

1649

WX882

NOMESCO Finland

High dependency care

4.6

29.4

164

M10.0

ICD-10 Finland

Idiopathic gout

4.0

29.4

220

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.9

29.4

J01FA06

ATC

roxithromycin; oral

1.8

29.4

674

4559

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

7.0

29.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

29.3

186

772

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.6

28.9

177

722

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.6

28.8

175

710

J01AA02

ATC

doxycycline; systemic

2.1

28.8

1272

10541

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.1

28.8

126

428

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

4.1

28.8

210

SPAT1216

SPAT

Assessment of functional ability

2.2

28.6

277

1386

N17.8

ICD-10 Finland

Other acute renal failure

7.3

28.5

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

5.2

28.4

117

R03AC03

ATC

terbutaline; inhalant

2.3

28.3

253

1224

E87.5

ICD-10 Finland

Hyperkalaemia

6.0

28.3

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.9

28.1

232

H02AB07

ATC

prednisone; oral

2.3

28.0

252

1223

A10BX01

ATC

guar gum; oral

3.9

28.0

228

WX872

NOMESCO Finland

Intensive care

3.1

28.0

120

403

C01DA14

ATC

isosorbide mononitrate; oral

2.3

28.0

249

1203

S06

ICPC

Rash localized

3.1

27.8

119

399

L14

ICPC

Leg/thigh symptom/complaint

2.7

27.7

162

645

P72

ICPC

Schizophrenia

5.0

27.3

121

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

27.3

291

1510

TQW80

NOMESCO Finland

Local dermatologic skincare

4.4

27.2

166

SPAT1097

SPAT

Recording of ECG

2.2

27.1

270

1365

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

26.9

605

4040

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.5

26.8

283

Z3229

NOMESCO Finland

Other healthcare associate professional

2.6

26.8

163

661

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.2

26.8

SPAT1167

SPAT

Insertion of urinary catheter

4.1

26.6

186

J01CF05

ATC

flucloxacillin; systemic

2.9

26.6

129

465

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

26.6

406

2397

P03

ICPC

Feeling depressed

2.7

26.6

155

616

WX721

NOMESCO Finland

Oxygen concentrator therapy

46.6

26.5

C09CA01

ATC

losartan; oral

1.9

26.4

449

2746

P99

ICPC

Psychological disorders other

4.3

25.9

164

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

5.4

25.7

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.2

25.6

232

1127

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

7.9

25.6

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

6.2

25.5

N05AC02

ATC

thioridazine; oral

5.2

25.5

105

N06AX11

ATC

mirtazapine; oral

1.8

25.5

562

3714

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.1

25.4

296

1585

R03AC12

ATC

salmeterol; inhalant

3.4

25.4

288

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

25.4

323

1786

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.0

25.4

120

426

L03.3

ICD-10 Finland

Cellulitis of trunk

8.4

25.3

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.1

25.3

109

367

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.5

25.2

173

743

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

25.1

670

4678

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.0

25.0

186

H02AB04

ATC

methylprednisolone; systemic

2.1

24.9

258

1321

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.2

24.8

104

344

A08AA10

ATC

sibutramine; oral

23.8

24.8

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.3

24.8

213

1011

WVA30, ,

SPAT

3.0

24.8

113

393

N02BF02

ATC

pregabalin; oral

2.9

24.7

126

466

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.2

24.7

161

S17

ICPC

Abrasion/scratch/blister

5.0

24.7

112

I48.2

ICD-10 Finland

Chronic atrial fibrillation

3.4

24.4

280

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.4

24.4

270

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.1

24.1

173

T07

ICPC

Weight gain

6.4

24.1

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

6.4

24.1

A04

ICPC

Weakness/tiredness general

2.1

24.0

244

1239

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

5.5

23.9

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.9

23.7

S29

ICPC

Skin symptom/complaint other

2.0

23.7

321

1810

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.3

23.7

D07AC01

ATC

betamethasone; topical

1.7

23.7

590

4022

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.8

23.4

N30.0

ICD-10 Finland

Acute cystitis

2.1

23.4

256

1336

C08CA02

ATC

felodipine; oral

2.4

23.4

173

769

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.7

23.3

128

493

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.6

23.2

126

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

23.1

220

1088

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

54.9

23.1

Z08

ICPC

Social welfare problem

6.6

23.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

23.0

435

2730

H3601, E113,

ICD-10 Finland

6.1

23.0

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

22.9

408

2513

J01MA02

ATC

ciprofloxacin; systemic

1.7

22.9

619

4305

R96

ICPC

Asthma

2.4

22.9

176

795

L03

ICPC

Low back symptom/complaint

1.8

22.8

452

2875

E86

ICD-10 Finland

Volume depletion

4.5

22.8

128

Z2446

NOMESCO Finland

Social worker

2.7

22.8

124

475

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.5

22.7

151

639

N05AA01

ATC

chlorpromazine; systemic, rectal

5.7

22.6

E66.1

ICD-10 Finland

Drug-induced obesity

121.8

22.6

A01

ICPC

Pain general/multiple sites

2.4

22.6

173

780

D07BC01

ATC

betamethasone and antiseptics; topical

2.2

22.5

221

1105

ZXE00

NOMESCO Finland

One hour or less

1.7

22.5

623

4355

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.4

22.5

161

704

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.2

22.5

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

22.5

140

574

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

32.8

22.4

J20

ICD-10 Finland

Acute bronchitis

2.3

22.2

179

825

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.6

22.2

N03AX11

ATC

topiramate; oral

4.2

22.2

148

A10BX09

ATC

[U] dapagliflozin

7.2

22.1

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

4.7

22.0

111

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.8

21.9

452

2904

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

8.6

21.9

J01DA09

ATC

[U] cefadroxil

1.8

21.9

435

2765

R03BB01

ATC

ipratropium bromide; inhalant

3.5

21.8

219

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

21.8

183

858

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.7

21.8

108

E87.6

ICD-10 Finland

Hypokalaemia

3.4

21.8

249

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

21.8

684

4935

XG460

NOMESCO Finland

Short time oxymetry

5.5

21.7

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

7.8

21.7

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

21.7

1111

9119

N05AF05

ATC

zuclopenthixol; systemic

7.0

21.7

S01

ICPC

Pain/tenderness of skin

3.1

21.7

323

R28

ICPC

Limited function/disability (R)

5.9

21.5

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

21.5

211

1055

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

4.5

21.4

122

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

21.3

252

1351

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.8

21.2

114

434

N30.9

ICD-10 Finland

Cystitis, unspecified

2.8

21.0

109

407

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.2

20.8

203

1011

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

6.9

20.8

L15

ICPC

Knee symptom/complaint

1.8

20.8

390

2430

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

7.2

20.8

T92

ICPC

Gout

4.4

20.8

125

C02EA02, ,

ATC

3.4

20.7

237

UKC02

NOMESCO Finland

Cystoscopy

2.0

20.7

265

1461

L03.9

ICD-10 Finland

Cellulitis, unspecified

4.7

20.6

105

H03AA01

ATC

levothyroxine sodium; systemic

1.8

20.6

388

2420

SPAT1125

SPAT

Stoma care and guidance

5.6

20.6

A02BC01

ATC

omeprazole; systemic

1.8

20.6

434

2799

C03BA11

ATC

indapamide; oral

3.9

20.6

161

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

20.6

592

4158

J01CE02

ATC

phenoxymethylpenicillin; oral

1.7

20.5

1045

8492

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.8

20.5

380

2360

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

20.5

460

3020

D09AB01

ATC

zinc bandage without supplements; topical

4.4

20.5

118

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

20.4

312

F32.1

ICD-10 Finland

Moderate depressive episode

2.8

20.4

106

396

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

7.3

20.4

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.6

20.3

119

473

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.9

20.2

154

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.8

20.2

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

20.1

367

2267

SPAT1151

SPAT

Treatment of major wounds

6.0

20.0

AA40B, ,

NOMESCO Finland

21.1

20.0

IHZ05, ,

SPAT

4.1

20.0

142

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.5

19.9

128

533

L60.0

ICD-10 Finland

Ingrowing nail

2.9

19.8

334

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

19.6

295

1714

QDA10

NOMESCO Finland

Incision of skin of lower limb

7.8

19.6

SPAT1241

SPAT

Extensive assessment of psychosocial situation

7.8

19.6

SPAT1251

SPAT

Organisation of medication

3.4

19.6

210

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

19.5

310

1833

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.4

19.4

145

646

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.6

19.4

182

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.1

19.3

193

971

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.4

19.2

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

26.4

19.1

R60.1

ICD-10 Finland

Generalized oedema

7.6

19.1

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

19.1

546

3811

C08DB01

ATC

diltiazem; oral

2.9

19.1

319

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.9

19.0

147

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.8

19.0

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.4

18.9

113

QDB10, ,

SPAT

4.5

18.8

105

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.8

18.8

P01AB01

ATC

metronidazole; oral, rectal

1.6

18.7

633

4603

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.1

18.6

253

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.9

18.5

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.7

18.5

164

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

18.5

203

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.8

18.4

354

R5110, ,

SPAT

2.5

18.4

121

509

E000006, ,

ATC

2.5

18.3

125

535

C09DA01

ATC

losartan and diuretics; oral

2.1

18.3

193

990

XA421

NOMESCO Finland

Nocturnal polygraphy

17.8

18.3

RK323, ,

NOMESCO Finland

19.6

18.2

A10AE06

ATC

insulin degludec; parenteral

3.3

18.2

220

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

3.5

18.2

190

R03AC13

ATC

formoterol; inhalant

2.7

18.2

100

385

K92.1

ICD-10 Finland

Melaena

2.7

18.1

368

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

18.0

124

532

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

18.0

368

2339

XF640, ,

NOMESCO Finland

3.8

18.0

153

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

18.0

293

1742

R04.0

ICD-10 Finland

Epistaxis

2.4

18.0

133

590

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.3

17.9

137

616

M79.7

ICD-10 Finland

Fibromyalgia

3.3

17.9

217

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

4.9

17.8

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

17.8

140

638

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.4

17.8

198

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

17.7

I48.1

ICD-10 Finland

Persistent atrial fibrillation

3.1

17.7

255

E000003, ,

ATC

2.9

17.7

304

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.4

17.7

128

562

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.2

17.7

224

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

17.4

331

2058

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.2

17.4

153

730

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

17.3

173

868

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.9

17.2

130

B01AB04

ATC

dalteparin; parenteral

2.8

17.2

338

SPAT1284

SPAT

Extensive health certificate

3.7

17.1

149

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

17.1

574

4144

S22

ICPC

Nail symptom/complaint

2.5

17.0

114

483

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.6

17.0

LCA06

NOMESCO Finland

Biopsy of endometrium

2.0

17.0

193

1016

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.8

16.9

306

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

3.4

16.9

184

Z3231

NOMESCO Finland

Registered nurse

1.7

16.9

417

2786

R03AK11

ATC

formoterol and fluticasone; inhalant

3.5

16.9

165

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.7

16.8

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

16.8

439

2974

L90

ICPC

Osteoarthrosis of knee

2.4

16.8

119

518

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

5.9

16.7

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

5.0

16.7

ZZA00

NOMESCO Finland

Split skin graft

3.3

16.7

191

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.6

16.6

152

N07BB01

ATC

disulfiram; oral

2.8

16.6

315

GD1AD

NOMESCO Finland

Thorax CT examination

2.4

16.6

114

489

YHMAS, ,

NOMESCO Finland

7.0

16.6

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.1

16.5

157

772

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.6

16.5

B80

ICPC

Iron deficiency anaemia

3.9

16.5

125

N05AF01

ATC

flupentixol; systemic

4.3

16.5

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.1

16.5

112

D01AE15

ATC

terbinafine; topical

2.3

16.5

126

567

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

3.1

16.4

234

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.2

16.4

108

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.4

16.4

183

N02AC04

ATC

dextropropoxyphene; oral

3.2

16.4

219

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

3.0

16.3

262

R52.9

ICD-10 Finland

Pain, unspecified

2.1

16.3

162

811

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.0

16.3

185

973

N02BF01

ATC

gabapentin; oral

2.2

16.3

149

722

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

16.3

356

2299

B01AB10

ATC

tinzaparin; parenteral

2.1

16.2

175

903

JN4AD

NOMESCO Finland

Body CT examination

2.1

16.2

175

903

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.3

16.2

189

N06AA04

ATC

clomipramine; systemic

4.4

16.2

SPAT1054

SPAT

Examination of peripheral nervous system

4.4

16.2

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

7.2

16.1

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

5.3

16.1

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.3

16.1

190

SPAT1252

SPAT

Overall medication plan or its review

2.4

16.1

119

528

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

16.1

448

3081

L73.2

ICD-10 Finland

Hidradenitis suppurativa

5.6

16.0

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.2

16.0

136

639

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

16.0

306

1902

R06AE07

ATC

cetirizine; oral

1.6

16.0

653

4914

K81.9

ICD-10 Finland

Cholecystitis, unspecified

6.2

16.0

S80.0

ICD-10 Finland

Contusion of knee

2.3

15.9

122

549

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.1

15.9

223

A07AA02

ATC

nystatin; oral

2.5

15.9

100

412

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

15.8

218

EBA10

NOMESCO Finland

Operative extraction of tooth

2.1

15.8

170

876

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.8

15.8

129

A69

ICPC

General and Unspecified, Other reason for encounter NEC

3.4

15.7

168

A10BD03

ATC

metformin and rosiglitazone; systemic

4.6

15.7

D07AC13

ATC

mometasone; topical

1.6

15.7

456

3166

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.1

15.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.1

15.6

220

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

15.5

137

654

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.6

15.5

145

W19

ICD-10 Finland

Unspecified fall

2.1

15.4

158

800

I26

ICD-10 Finland

Pulmonary embolism

6.5

15.4

SPAT1276

SPAT

Outlining of treatment with patient or their family members

3.8

15.4

127

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.9

15.4

271

P06

ICPC

Sleep disturbance

2.0

15.4

185

993

GBB00

NOMESCO Finland

Tracheostomy

5.3

15.4

R32

ICD-10 Finland

Unspecified urinary incontinence

3.6

15.3

146

M09AX01

ATC

hyaluronic acid; parenteral

2.7

15.3

329

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.7

15.3

312

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.8

15.2

128

M02AA07

ATC

piroxicam; topical

1.6

15.2

559

4096

N05AB01

ATC

dixyrazine; systemic

5.0

15.0

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

15.0

443

3080

AN1

Coronary angiography

2.0

15.0

173

914

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.0

15.0

236

SPAT1377

SPAT

Polysomnography

2.9

15.0

247

M48.0

ICD-10 Finland

Spinal stenosis

1.9

14.9

203

1135

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

3.6

14.9

144

N05BA12

ATC

alprazolam; oral

2.0

14.9

171

902

EBA30

NOMESCO Finland

Extraction of root of tooth

2.4

14.9

105

456

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.1

14.8

103

TK800

NOMESCO Finland

Hemodialysis

3.8

14.8

121

SPAT1051

SPAT

Guidance regarding sleep disorders

4.4

14.8

AA43B, ,

NOMESCO Finland

57.2

14.8

R4180

NOMESCO Finland

Podiatric therapy

4.8

14.7

KGH10

NOMESCO Finland

Operation for phimosis

3.4

14.7

155

A41.8

ICD-10 Finland

Other specified sepsis

4.0

14.6

104

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.1

14.6

207

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

14.6

242

1440

-56

ICPC

Dressing/pressure/compress/tamponade

4.3

14.6

A10BB07

ATC

glipizide; oral

6.4

14.6

UJF32

NOMESCO Finland

Coloscopy

1.6

14.5

412

2833

SGA01

NOMESCO Finland

Emergency treatment

1.8

14.5

252

1521

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

14.5

145

728

J98.6

ICD-10 Finland

Disorders of diaphragm

15.5

14.4

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.7

14.4

298

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

14.4

118

547

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.3

14.3

173

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

14.3

343

2262

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

14.3

126

602

J01CA04

ATC

amoxicillin; systemic

1.6

14.3

1231

10819

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.9

14.2

238

F32

ICD-10 Finland

Depressive episode

2.6

14.2

348

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.7

14.2

B37.2

ICD-10 Finland

Candidiasis of skin and nail

6.5

14.1

WX290

NOMESCO Finland

Other blockage of nerve

1.5

14.1

679

5252

E61.1

ICD-10 Finland

Iron deficiency

4.1

14.1

R03AC18

ATC

indacaterol; inhalant

6.7

14.0

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.1

14.0

196

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.3

14.0

165

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.0

14.0

170

914

R33

ICD-10 Finland

Retention of urine

2.2

14.0

120

567

F31

ICD-10 Finland

Bipolar affective disorder

5.3

13.9

N05BA02

ATC

chlordiazepoxide; systemic

3.3

13.9

166

OAB43, ,

SPAT

0.5

13.9

142

2594

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.7

13.8

118

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.2

13.8

167

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.3

13.8

D05AX52

ATC

calcipotriol, combinations; topical

2.4

13.8

396

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.8

13.8

259

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

4.2

13.7

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

5.8

13.7

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.9

13.7

200

1144

D75.1

ICD-10 Finland

Secondary polycythaemia

6.5

13.7

L16

ICPC

Ankle symptom/complaint

1.9

13.6

176

967

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.0

13.6

153

801

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

13.6

102

455

K02.1

ICD-10 Finland

Caries of dentine

1.5

13.5

864

7062

N06AB05

ATC

paroxetine; oral

2.3

13.5

102

456

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

13.5

431

GX1P5

NOMESCO Finland

Nocturnal CO2 monitoring

141.2

13.5

M01AX17

ATC

nimesulide; oral

1.6

13.5

376

2570

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

13.4

829

6727

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

13.4

372

2540

N06AX05

ATC

trazodone; oral

3.2

13.4

165

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

13.4

414

N03AF02

ATC

oxcarbazepine; oral

3.0

13.3

202

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.5

13.3

GD2SN

NOMESCO Finland

Lung ventilation SPECT

6.4

13.3

R11

ICD-10 Finland

Nausea and vomiting

2.1

13.3

133

667

C09DA03

ATC

valsartan and diuretics; oral

2.5

13.3

359

N06AX26

ATC

vortioxetine; oral

2.3

13.2

107

493

D07XC01

ATC

betamethasone; topical

1.9

13.2

195

1118

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.7

13.2

282

C07AB03

ATC

atenolol; systemic

2.3

13.2

429

S89.9

ICD-10 Finland

Unspecified injury of lower leg

3.0

13.2

198

XA420

NOMESCO Finland

Extensive sleep examination

5.2

13.2

N06AG02

ATC

moclobemide; oral

2.6

13.2

312

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.6

13.2

318

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

13.1

701

5515

A10AB04

ATC

insulin lispro; parenteral

3.1

13.1

188

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.7

13.1

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

3.7

13.1

113

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

13.0

168

922

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.7

13.0

261

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

13.0

369

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

5.3

13.0

SPAT1058

SPAT

PEF monitoring instruction

2.1

12.9

129

646

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

12.9

143

744

A01AB09

ATC

miconazole; local oral

2.1

12.9

135

688

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.1

12.9

179

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.0

12.9

195

K93

ICPC

Pulmonary embolism

5.1

12.9

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

2.8

12.9

245

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.9

12.9

ZY010

NOMESCO Finland

Hospital outpatient

2.5

12.9

340

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

12.8

114

546

N06AA12

ATC

doxepin; systemic

2.4

12.8

390

D07AA02

ATC

hydrocortisone; topical

1.8

12.8

196

1137

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.6

12.8

287

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

12.8

396

2770

C09DA06

ATC

candesartan and diuretics; oral

2.1

12.7

126

629

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

12.7

213

1268

G04BD04

ATC

oxybutynin; oral, transdermal

2.4

12.7

385

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.6

12.7

276

C07AG02

ATC

carvedilol; oral

2.3

12.6

431

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.7

12.6

SPAT1143

SPAT

Partial or complete excision of nail

6.0

12.6

P28

ICPC

Limited function/disability (P)

5.5

12.6

Z3226

NOMESCO Finland

Physiotherapist

1.7

12.6

274

1756

E11.01

ICD-10 Finland

Non-insulin dependent diabetes diabetic coma with hyperglycaemia

32.3

12.6

N05AE04

ATC

ziprasidone; systemic

11.1

12.5

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.4

12.5

363

RK250, ,

NOMESCO Finland

10.1

12.5

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

12.5

105

492

K78

ICPC

Atrial fibrillation/flutter

2.1

12.5

120

593

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

12.5

269

1720

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.5

12.4

327

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.2

12.4

107

506

ACC51

NOMESCO Finland

Release of median nerve

2.1

12.4

129

656

SPAT1325

SPAT

Vaccination

1.5

12.4

466

3398

QXB99, ,

SPAT

3.5

12.4

122

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019060) Gas panel - Arterial blood

554

840

9.66

307.65

5.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

452

698

8.70

296.39

6.8

3.4

4.47

1.69

mmol/l

25.19

392

533

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

461

731

8.52

295.33

7.1

3.4

6.10

5.11

kpa

41.99

448

707

(3009343) pH of Capillary blood

458

724

8.53

294.12

7.1

3.4

7.40

7.41

1.47

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

625

1465

6.44

271.78

10.0

7.9

6.28

5.07

kpa

67.23

610

1399

(3027801) Oxygen [Partial pressure] in Arterial blood

625

1465

6.44

271.78

10.0

7.9

8.86

12.40

kpa

78.62

605

1400

(3003396) Base excess in Arterial blood by calculation

623

1464

6.41

269.97

10.1

8.0

3.83

1.04

mmol/l

40.10

562

1164

(3016502) Oxygen saturation in Arterial blood

548

1318

5.86

227.10

9.6

8.4

91.58

95.75

29.19

531

1266

(1616796) Gas panel - Central venous blood

234

247

10.96

203.96

8.0

3.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

901

3574

4.58

194.94

4.8

2.9

1593.25

1247.74

ng/l

0.98

775

3061

(3023368) Bacteria identified in Blood by Culture

879

3429

4.57

194.40

7.1

4.3

—

(3027315) Oxygen [Partial pressure] in Blood

211

257

9.33

164.33

9.7

3.4

8.21

8.60

kpa

1.78

206

251

(3013290) Carbon dioxide [Partial pressure] in Blood

211

257

9.33

164.33

9.7

3.4

5.76

4.98

kpa

16.14

206

251

(3021901) Oxygen saturation in Capillary blood

194

213

10.26

163.48

5.2

2.6

—

(3012501) Base excess in Blood by calculation

210

257

9.28

162.91

9.7

3.4

4.73

2.40

mmol/l

9.49

173

165

(3010421) pH of Blood

230

316

8.36

162.31

9.4

3.1

7.41

7.42

0.92

211

275

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

326

657

6.00

159.60

10.7

10.3

26.66

24.32

mmol/l

20.57

317

642

(3003458) Phosphate [Moles/volume] in Serum or Plasma

527

1615

4.41

155.73

5.7

5.6

1.08

1.02

mmol/l

4.21

483

1486

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

336

718

5.69

154.07

11.4

7.3

28.23

24.75

mmol/l

24.58

331

712

(3022313) Gas panel - Capillary blood

282

521

6.38

150.72

7.8

3.6

—

(40767503) Oxygen content in Capillary blood by calculation

194

245

8.90

146.40

5.3

2.4

16.07

16.47

0.49

134

129

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

580

2030

3.95

140.48

2.8

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

865

3983

3.62

136.98

4.4

3.6

12.60

7.66

mg/mmol

2.04

553

2453

(3012095) Magnesium [Moles/volume] in Serum or Plasma

573

2025

3.89

136.22

3.1

3.5

0.82

mmol/l

0.00

523

1901

(3002173) Hemoglobin [Mass/volume] in Arterial blood

424

1238

4.33

131.34

11.3

8.9

132.35

121.49

g/l

17.06

419

1200

(3012516) Albumin [Mass/volume] in Urine

825

3770

3.51

130.55

3.5

3.2

513.41

353.48

mg/l

0.39

544

2363

(3009508) Creatinine [Moles/volume] in Urine

840

3971

3.41

124.05

3.5

3.1

7.34

7.54

mmol/l

0.61

661

3364

(3022217) INR in Platelet poor plasma by Coagulation assay

1079

5945

3.62

123.78

22.9

14.7

1.27

1.25

inr

0.40

442

1739

(3024561) Albumin [Mass/volume] in Serum or Plasma

1026

5506

3.51

122.26

5.7

4.8

32.89

35.70

g/l

46.90

963

5136

(3006184) Hemoglobin [Mass/volume] in Capillary blood

179

263

7.56

118.19

4.3

2.1

133.88

131.39

g/l

0.47

152

190

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

426

1351

3.96

116.34

6.1

3.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

443

1449

3.87

115.62

2.4

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

698

3085

3.28

112.75

3.0

2.1

4.28

2.96

mg/l

17.49

599

2622

(3008152) Bicarbonate [Moles/volume] in Arterial blood

314

815

4.57

112.19

11.3

7.6

28.33

24.47

mmol/l

32.10

305

772

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

227

454

5.68

110.28

8.5

3.8

26.62

24.86

mmol/l

10.00

218

425

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

464

1657

3.56

104.96

3.1

2.5

17.37

23.66

18.04

384

1400

(3020891) Body temperature

232

499

5.28

103.69

7.7

4.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

479

1765

3.47

102.89

3.0

2.4

2.49

2.31

g/l

7.01

420

1641

(3002032) Base excess in Venous blood by calculation

361

1108

3.94

102.16

5.2

3.5

4.84

1.84

mmol/l

23.39

327

920

(3021447) Carbon dioxide [Partial pressure] in Venous blood

362

1117

3.92

101.62

5.2

3.5

7.20

5.81

kpa

36.57

346

1085

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

913

4926

3.05

100.63

6.4

3.4

37.33

47.70

ng/l

0.64

734

3389

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1022

5877

3.13

100.25

11.4

5.9

1.19

1.21

mmol/l

15.11

938

5370

(40761536) Microorganisms panel - Urine sediment

352

1075

3.93

100.17

5.6

3.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

555

2275

3.23

99.59

2.5

1.7

1412.12

1180.75

nmol/l

5.13

406

1718

(3012544) pH of Venous blood

362

1140

3.83

98.41

5.2

3.6

7.35

7.40

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

228

510

5.06

97.13

2.5

2.0

1.88

1.60

ug/l

0.14

203

454

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

411

1423

3.56

96.71

2.6

1.7

—

(3017569) Oxygen content in Arterial blood

15.44

96.14

2.4

2.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

494

1929

3.28

95.63

3.1

2.4

10.18

13.48

umol/l

21.90

439

1798

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

411

1434

3.53

95.43

2.6

1.7

—

(3026008) Bacteria identified in Urine by Culture

753

3736

2.96

95.34

4.5

3.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

608

2692

3.06

94.56

2.5

1.6

438.90

44529582.13

pmol/l

3.26

483

2230

(3020779) Urea [Moles/volume] in Serum or Plasma

348

1107

3.76

92.79

7.3

7.8

12.66

9.25

mmol/l

10.87

337

1057

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1065

6445

3.04

91.86

11.3

6.7

1.18

1.21

mmol/l

23.12

830

5490

(40760892) CBC W Ordered Manual Differential panel - Blood

1025

6117

2.96

89.93

8.3

6.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1177

7587

3.22

89.48

11.2

4.7

7.49

6.65

mmol/l

19.85

1127

7143

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

619

2866

2.92

87.43

2.0

1.8

1.11

1.14

mg/l

0.13

504

2184

(3014111) Lactate [Moles/volume] in Serum or Plasma

339

1116

3.60

85.28

11.5

7.2

1.45

1.37

mmol/l

0.61

330

1091

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

328

1065

3.63

84.19

5.5

3.3

1.20

1.23

mmol/l

8.48

274

920

(3026493) Urate [Moles/volume] in Serum or Plasma

681

3438

2.74

79.92

3.3

2.6

1973.64

5605.76

umol/l

2.57

573

3023

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1072

6803

2.83

79.14

6.5

6.4

11.14

11.56

umol/l

0.37

1004

6482

(3019977) pH of Arterial blood

12.39

77.71

2.6

3.4

7.41

7.42

0.56

(3024354) Oxygen [Partial pressure] in Venous blood

289

911

3.66

77.13

4.9

2.7

4.97

4.57

kpa

1.83

273

883

(3019069) Monocytes/100 leukocytes in Blood

989

6099

2.69

76.00

7.7

6.3

8.30

8.68

3.43

945

5703

(3042936) Bacteria identified in Isolate by Culture

443

1824

2.99

75.97

2.8

2.1

—

(3000991) Gas panel - Venous blood

310

1038

3.48

75.28

12.1

8.6

—

(3013115) Eosinophils [#/volume] in Blood

1054

6725

2.74

75.27

7.7

6.0

0.19

e9/l

0.55

941

5926

(3001604) Monocytes [#/volume] in Blood

1029

6493

2.71

75.07

7.2

5.8

0.65

0.58

e9/l

18.10

922

5635

(3006315) Basophils [#/volume] in Blood

1030

6503

2.71

75.04

7.2

5.8

0.04

e9/l

0.03

918

5643

(3006504) Eosinophils/100 leukocytes in Blood

984

6078

2.67

74.94

7.4

6.0

2.52

2.86

5.51

940

5680

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

248

732

3.84

72.70

2.0

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

1039

6652

2.67

72.46

7.3

5.8

1.81

1.95

e9/l

1.86

939

5904

(3002030) Lymphocytes/100 leukocytes in Blood

995

6248

2.63

72.08

7.6

6.1

22.86

28.01

43.42

953

5867

(3022096) Basophils/100 leukocytes in Blood

958

5912

2.60

71.91

7.5

6.0

0.56

0.69

12.39

912

5520

(3001122) Ferritin [Mass/volume] in Serum or Plasma

884

5305

2.53

69.59

4.3

2.7

119.94

137.07

ug/l

1.67

792

4908

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

735

4070

2.52

68.56

3.3

2.5

46.16

80.58

u/l

1.08

664

3768

(3036481) Cortisol [Moles/volume] in Serum or Plasma

314

1130

3.23

67.30

2.2

2.1

310.55

373.27

nmol/l

5.76

289

1046

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

328

1213

3.16

67.11

2.5

2.2

0.19

0.22

g/l

5.06

300

1144

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

272

899

3.45

66.92

1.9

1.6

—

(3026782) Osmolality of Urine

526

2512

2.65

66.62

3.5

2.8

512.83

542.35

mosm/kgh2o

2.36

461

2171

(3018010) Neutrophils/100 leukocytes in Blood

968

6156

2.50

65.71

7.3

5.9

62.68

56.98

41.99

926

5775

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

144

308

5.05

63.94

1.8

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

156

363

4.66

62.57

2.2

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

140

300

5.03

61.99

1.8

1.7

—

(3018418) pH of Serum or Plasma

685

3869

2.37

58.71

5.5

3.9

7.40

0.69

253

736

(3000850) Epithelial cells [#/volume] in Urine

527

2654

2.49

58.37

3.5

2.5

8.15

5.46

e6/l

3.57

479

2406

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

115

226

5.41

56.11

1.7

1.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1328

10194

3.00

55.38

10.3

7.5

87.50

77.77

u/l

6.28

1265

9625

(3031040) Bacteria [#/volume] in Urine by Automated count

1160

8372

2.49

54.30

7.3

4.2

227.11

2308.85

e6/l

1.70

115

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

832

5254

2.25

52.98

3.3

2.2

69.78

78.39

nmol/l

17.00

746

4713

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

103

7.60

52.01

1.8

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

820

5176

2.23

51.92

2.6

1.9

91.06

95.50

pmol/l

1.93

501

2675

(3013650) Neutrophils [#/volume] in Blood by Automated count

1077

7602

2.34

51.75

10.8

9.2

5.21

4.02

e9/l

37.93

967

6681

(3029937) Albumin [Presence] in Urine by Test strip

605

3382

2.29

51.53

5.7

3.8

0.00

estimate

0.18

300

1128

(3040151) Glucose [Moles/volume] in Capillary blood

126

6.81

51.37

6.9

7.7

7.59

7.23

mmol/l

0.42

106

(3021960) Folate [Moles/volume] in Serum or Plasma

544

2920

2.32

50.90

1.9

1.5

19.34

20.89

nmol/l

1.63

465

2489

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

140

6.28

48.64

1.8

1.7

—

(3013512) EKG study

648

3794

2.21

48.61

5.2

3.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

718

4379

2.18

48.57

3.1

3.5

2.33

2.35

mmol/l

3.75

626

3889

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

186

5.49

48.55

1.8

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

131

324

4.32

48.40

1.4

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

256

982

2.92

48.00

3.9

4.1

0.63

0.70

0.22

324

(3037467) Urinalysis macro (dipstick) panel - Urine

1185

8851

2.40

47.76

6.3

4.2

—

(3021589) Normoblasts [#/volume] in Blood

872

5784

2.15

46.94

18.9

9.2

0.00

e9/l

0.37

753

4755

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

697

4249

2.15

46.69

3.2

31.57

32.96

u/l

0.48

641

4050

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

189

5.35

46.66

1.7

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

104

220

4.99

46.57

1.7

1.5

—

(3025159) Blasts/100 leukocytes in Blood

250

965

2.89

46.24

4.7

4.3

0.00

0.42

0.69

265

(3021440) Promyelocytes/100 leukocytes in Blood

259

1019

2.85

46.24

4.6

4.3

0.04

0.12

2.10

317

(3002582) Erythrocytes [#/volume] in Urine

646

3835

2.17

46.21

4.2

3.1

70.89

75.26

e6/l

0.06

552

2944

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

145

401

3.88

45.98

3.1

3.3

0.39

0.36

u/ml

0.60

226

(3027273) Bicarbonate [Moles/volume] in Venous blood

179

575

3.39

45.31

5.0

3.2

28.57

25.22

mmol/l

12.69

168

558

(3017181) Myelocytes/100 leukocytes in Blood

265

1076

2.76

44.45

4.6

4.2

0.99

1.01

0.03

374

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

168

5.49

44.23

1.7

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

313

1407

2.53

42.61

2.3

2.6

2.17

1.79

6.71

256

1261

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

165

527

3.38

42.07

6.6

3.4

53.67

49.42

1.21

159

522

(4200892) Spirometry reversibility

232

911

2.82

41.32

1.7

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

175

5.21

41.24

1.7

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

592

3521

2.10

40.97

4.1

3.0

0.88

0.45

e6/l

2.73

509

2676

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

201

735

2.99

40.77

2.6

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

196

708

3.02

40.62

15.3

11.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

7.88

39.68

1.8

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

909

6371

2.02

39.28

5.2

3.5

0.01

estimate

0.20

293

1130

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

248

1035

2.66

39.12

4.5

3.0

186.63

194.62

ng/l

0.12

232

941

(36304419) Bacteria [Presence] in Urine

577

3452

2.06

38.85

4.0

3.0

—

(3035350) Ketones [Presence] in Urine by Test strip

900

6306

2.01

38.68

5.2

3.5

0.00

estimate

0.75

336

1236

(3018095) Leukocytes [#/volume] in Urine

694

4453

2.00

38.28

4.9

3.6

89.93

103.69

e6/l

0.16

569

3168

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

215

4.59

38.26

3.5

2.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

7.63

37.90

1.8

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

200

759

2.87

37.82

4.8

3.0

134.94

128.37

g/l

3.09

190

741

(3041096) Erythrocytes [Presence] in Urine by Automated

571

3431

2.05

37.75

5.2

3.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

897

6310

1.99

37.73

6.4

4.7

0.00

estimate

0.50

326

1166

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

7.09

37.47

1.8

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

110

290

4.00

37.18

3.1

3.2

36.26

33.94

umol/l

0.53

103

265

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

626

3914

2.00

36.79

2.8

2.1

162.05

214.25

u/l

1.38

581

3691

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

154

520

3.18

35.71

7.7

6.4

2.35

1.60

4.79

147

481

(3023520) Reticulocytes [#/volume] in Blood

240

1056

2.50

33.65

2.5

2.7

85.06

70.81

e9/l

6.63

182

822

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

135

440

3.26

33.15

2.2

2.4

445.89

469.45

ug/l

0.06

127

409

(3007930) Methemoglobin/Hemoglobin.total in Blood

147

519

3.02

31.49

8.2

6.4

0.81

0.91

1.98

141

481

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

102

296

3.62

30.00

2.5

2.3

216.20

110.74

ug/min

0.59

179

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1226

9976

2.06

29.97

5.1

4.0

14.85

14.79

pmol/l

0.33

1120

9082

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1419

12300

2.65

28.83

10.3

5.4

46.68

39.51

mmol/mol

75.16

1318

11403

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

284

1455

2.16

27.58

2.5

4.7

235.07

246.86

u/l

0.84

254

1377

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

703

4882

1.80

27.56

5.8

3.6

—

(3000494) Fungus identified in Specimen by Culture

298

1557

2.13

27.51

1.6

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

211

961

2.38

27.14

4.3

3.7

120.93

88.28

ng/l

3.75

172

846

(3020630) Protein [Mass/volume] in Serum or Plasma

225

1054

2.33

27.13

1.8

2.9

66.38

66.63

g/l

0.18

198

964

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1095

8699

1.86

27.07

4.8

3.1

61.39

50.08

u/l

4.57

1009

8126

(3047181) Lactate [Moles/volume] in Blood

120

413

3.06

26.82

11.1

7.6

1.36

1.31

mmol/l

0.29

110

358

(3009466) Valproate [Moles/volume] in Serum or Plasma

185

4.03

25.17

6.4

4.9

377.24

365.56

umol/l

0.28

163

(3023419) Bacteria identified in Sputum by Culture

200

3.89

24.91

3.3

2.6

—

(3003338) MCHC [Mass/volume]

918

11155

0.57

24.48

41.7

17.9

322.78

332.59

g/l

102.75

908

11078

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

110

385

3.00

23.85

2.1

3.9

1.29

1.65

ratio

—

(3044242) Glucose [Moles/volume] in Arterial blood

6.16

23.81

2.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

111

392

2.97

23.69

2.1

3.9

57.85

64.91

mg/l

0.17

319

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

111

394

2.96

23.47

2.1

3.9

57.65

84.30

mg/l

0.34

322

(3013707) Erythrocyte sedimentation rate by Westergren method

1176

9742

1.83

23.13

5.5

4.0

22.68

11.66

mm/h

52.00

1078

9007

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

245

3.48

23.06

1.8

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

245

3.48

23.06

1.8

1.3

—

(3015736) pH of Urine

702

5052

1.71

22.94

4.2

3.3

5.52

5.84

1.65

375

(3005322) IgE [Units/volume] in Serum or Plasma

171

780

2.34

21.75

1.5

1.2

189.09

197.98

u/ml

0.11

162

717

(40760888) Immunoglobulin light chains.free panel - Serum

299

3.13

21.34

2.0

4.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

229

3.44

21.10

3.6

3.1

0.89

0.84

nmol/l

0.29

177

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

123

488

2.65

21.07

3.1

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

114

442

2.70

20.43

2.9

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1362

12010

2.03

19.80

6.4

4.7

2.01

2.03

mu/l

0.09

1256

11001

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

209

3.46

19.72

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

209

3.46

19.72

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

333

2.91

19.35

2.7

2.8

2.10

1.52

mg/l

4.33

307

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

183

3.60

19.25

5.5

7.5

11.70

11.63

mg/l

0.04

173

(3000012) Reticulocyte production index

170

3.69

19.05

1.9

2.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

5.56

18.89

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

5.56

18.89

1.5

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

180

891

2.15

18.71

1.9

2.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

6.14

18.61

3.7

4.0

—

(3018572) Chloride [Moles/volume] in Blood

301

2.89

17.46

10.7

8.8

103.21

105.32

mmol/l

3.81

265

(3039000) Anion gap in Blood

301

2.89

17.46

10.7

8.8

10.04

11.29

mmol/l

2.08

265

(3005719) IgG [Mass/volume] in Serum or Plasma

188

983

2.04

16.85

2.8

10.64

10.51

g/l

0.13

166

899

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

106

437

2.53

16.78

1.8

1.5

102.22

137.14

titre

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

129

585

2.31

16.56

1.3

1.8

1.79

1.54

g/l

2.03

104

504

(3004809) Band form neutrophils/100 leukocytes in Blood

199

3.26

16.26

1.9

4.0

0.88

1.48

1.21

183

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1201

0.24

16.26

1.9

1.8

—

(3025941) Bacteria identified in Stool by Culture

141

670

2.21

16.19

1.4

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

155

765

2.14

16.18

2.2

1.8

1.21

1.39

g/l

0.54

143

700

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

366

2388

1.70

16.08

3.2

3.0

2.49

2.45

mmol/l

6.99

319

2127

(3024928) Oxygen saturation in Venous blood

272

2.89

15.85

3.1

2.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

257

1523

1.82

15.78

2.3

1.8

1.49

1.51

0.20

216

1321

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

378

2509

1.67

15.49

6.1

3.6

192.16

383.80

ng/l

1.54

329

1953

(3004451) EKG impression Narrative

5.25

15.36

1.2

—

(21494755) Public health laboratory ask at order entry panel

1207

0.27

15.00

1.5

1.4

—

(4146454) Self-monitoring of blood glucose

120

3.83

15.00

3.3

2.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1431

13098

2.08

14.95

37.6

13.7

27.29

23.87

mg/l

3.85

1362

10239

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

198

1108

1.90

14.51

3.0

2.4

4.61

7.51

ug/l

2.67

159

992

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

259

2.82

14.31

1.8

1.5

1.42

0.83

nmol/l

2.70

220

(3018677) aPTT in Platelet poor plasma by Coagulation assay

311

2003

1.69

14.15

2.5

2.0

31.00

29.59

3.39

303

1939

(40768797) Stomach Pathology biopsy report

293

1862

1.71

14.00

1.3

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

243

1469

1.77

13.85

2.6

2.7

7.06

8.37

umol/l

0.42

187

1291

(3045716) Anion gap in Serum or Plasma

4.65

13.79

4.5

2.7

8.63

10.01

mmol/l

0.82

(40758558) Short blood count panel - Blood

465

3330

1.56

13.67

7.3

6.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

324

2.58

13.67

1.5

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

115

3.73

13.51

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

115

3.73

13.51

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

115

3.73

13.51

1.5

1.6

—

(3004775) Volume in Urine collected for unspecified duration

3.99

13.47

2.0

2.3

818.45

655.15

0.89

(3042631) Mycobacterium sp identified in Specimen

180

3.13

13.43

3.1

2.5

—

(3037522) Nuclear Ab [Titer] in Serum

270

1702

1.71

13.23

1.3

484.53

509.16

titre

0.10

369

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

368

2.44

13.06

1.4

1.6

0.26

0.23

g/l

1.56

349

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

215

2.86

12.53

1.2

1.3

24.29

30.80

u/l

0.29

184

(3016750) Collection duration of Urine

4.28

12.48

2.1

475.24

497.61

min

0.62

(46235355) HIV 1 and 2 tests - Meaningful Use set

281

1817

1.67

12.46

1.7

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.90

12.39

1.3

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

385

2.36

12.28

1.4

1.6

1.30

1.17

g/l

3.19

364

(3037756) Immunofixation for Serum or Plasma

282

2.59

12.17

1.3

1.7

—

(3011985) Renin [Units/volume] in Plasma

159

3.15

12.16

1.2

1.3

123.54

62.80

mu/l

0.60

143

(3024139) IgG subclass 3 [Mass/volume] in Serum

110

3.61

12.04

1.4

1.3

0.33

0.36

g/l

0.25

(3027135) IgG subclass 1 [Mass/volume] in Serum

110

3.61

12.04

1.4

1.3

7.58

7.09

g/l

0.19

(3028192) IgG subclass 2 [Mass/volume] in Serum

110

3.61

12.04

1.4

1.3

2.45

2.89

g/l

0.53

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.71

11.96

4.5

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.71

11.96

4.5

2.9

—

(3006653) Thiamine [Moles/volume] in Blood

4.72

11.91

1.3

1.2

147.04

143.21

nmol/l

0.11

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

146

3.22

11.84

1.7

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

146

3.22

11.84

1.7

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1465

13694

2.09

11.79

43.4

15.6

139.71

139.70

mmol/l

0.03

1434

13347

(3017143) Hepatitis C virus Ab [Presence] in Serum

210

1274

1.75

11.73

1.6

—

(4062490) Immunoglobulin typing, IgG

113

3.51

11.58

1.5

1.3

—

(3020491) Glucose [Moles/volume] in Blood

3.90

11.40

3.1

1.6

6.85

6.87

mmol/l

0.02

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

130

3.29

11.27

1.6

1.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1466

13736

2.06

11.25

43.4

15.7

4.01

3.97

mmol/l

6.77

1435

13373

(3021788) Differential panel - Synovial fluid

246

2.63

11.20

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

390

2.28

11.06

1.6

1.5

280.76

286.29

ug/g

0.08

238

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

141

771

1.91

11.03

2.9

3.5

4.29

4.49

pmol/l

1.17

118

681

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.69

10.96

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.69

10.96

1.6

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

170

2.94

10.87

1.7

1.6

74.22

59.37

1.59

110

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

8.57

10.54

4.2

1.6

5.42

7.94

mmol/l

1.16

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

121

3.28

10.44

1.6

1.4

18.76

32.32

1.57

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

147

3.05

10.43

1.3

364.90

330.55

pmol/l

0.20

133

(44816559) Phosphatidylethanol [Mass/volume] in Blood

214

2.68

10.40

1.3

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

142

3.09

10.40

1.6

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

4.05

10.24

1.1

1.4

2.11

1.17

nmol/l

2.76

(3007566) Smooth muscle Ab [Titer] in Serum

320

2.34

10.17

1.0

1.2

66.00

65.42

titre

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

166

2.89

10.12

1.0

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

271

2.46

10.12

1.7

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

367

2.24

10.03

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

440

2.13

10.02

3.4

2.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

796

0.27

9.99

1.2

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

135

3.09

9.97

1.6

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

3.76

9.89

1.5

1.3

38.17

16.28

u/ml

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

210

2.63

9.71

1.2

—

(3014271) Vancomycin [Susceptibility]

4.34

9.60

3.8

2.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

374

2738

1.48

9.36

1.3

1.2

2.19

1.53

u/ml

0.33

129

738

(3025468) Yersinia sp identified in Specimen by Organism specific culture

157

2.85

9.32

1.8

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

157

2.85

9.32

1.8

1.5

—

(3044889) 12 lead EKG panel

1079

9535

1.42

9.23

5.8

3.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

158

2.84

9.22

1.8

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

436

3307

1.44

9.03

5.1

3.8

84.39

90.50

4.59

421

3220

(3024980) IgG subclass 4 [Mass/volume] in Serum

183

2.67

8.99

1.4

1.6

0.63

0.88

g/l

0.76

135

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.95

8.88

1.6

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.95

8.88

1.6

1.9

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

6.85

8.84

1.4

1.8

64.60

91.90

nmol/24h

0.64

(3003181) Sodium [Moles/volume] in Urine

228

2.46

8.70

1.4

1.3

66.47

60.03

mmol/l

0.32

189

(3017732) Neutrophils [#/volume] in Blood

148

884

1.74

8.69

3.0

3.1

5.04

5.62

e9/l

0.31

113

714

(3024522) Salmonella sp identified in Specimen by Organism specific culture

158

2.77

8.65

1.8

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

158

2.77

8.65

1.8

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

125

3.01

8.65

2.1

4.2

64.88

52.76

3.61

111

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

157

2.72

8.19

1.8

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

3.94

8.16

1.7

1.8

2.06

5.28

nmol/l

0.47

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.21

8.10

1.0

1.2

—

u/ml

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

725

6075

1.36

8.09

3.0

2.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

218

2.43

8.05

1.3

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

326

2388

1.46

8.00

1.8

1.5

3.06

2.46

g/l

4.38

225

1482

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

218

1470

1.56

7.95

1.7

1.6

—

(3022145) Colonoscopy Study observation

224

1520

1.55

7.94

1.4

1.3

—

(3000492) Spirometry study

196

1292

1.59

7.88

1.7

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.08

7.81

1.6

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.08

7.81

2.5

—

(3012441) Differential panel - Pleural fluid

117

2.95

7.72

1.4

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

504

4010

1.38

7.70

2.9

2.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

103

576

1.84

7.55

1.9

34.40

39.38

u/l

1.55

502

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

165

2.59

7.46

1.3

—

(40768443) Skin Pathology biopsy report

100

565

1.82

7.11

1.3

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.88

6.99

1.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.88

6.99

1.7

2.0

—

(3028707) Methadone [Presence] in Urine by Screen method

136

2.69

6.92

3.1

2.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

114

2.84

6.86

1.5

2.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

137

2.67

6.83

2.3

4.6

—

(3008295) Osmolality of Serum or Plasma

138

2.65

6.74

1.2

1.3

281.00

277.25

mosm/kgh2o

0.35

106

(3000093) Morphology [Interpretation] in Blood Narrative

110

2.85

6.70

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

898

7899

1.32

6.67

3.4

2.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

416

1.92

6.64

2.3

2.7

1.12

1.22

g/l

0.08

369

(3019225) pH of Specimen

188

1276

1.54

6.63

6.0

4.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

453

3614

1.36

6.62

1.8

1.7

1.80

1.37

mmol/l

8.84

325

3032

(3012565) Volume of 24 hour Urine

3.59

6.60

1.7

2.6

1404.38

2080.00

2.40

(3035880) pH of Pleural fluid

3.47

6.57

1.2

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

10.07

6.53

1.6

2.3

45.68

40.83

umol/l

0.32

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

287

2.10

6.49

1.5

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

3.16

6.45

2.6

1.4

12.12

13.45

u/l

0.53

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

179

2.38

6.34

1.0

1.1

1.58

1.52

g/l

0.52

163

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

155

2.49

6.30

1.2

—

nmol/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1373

12948

1.49

6.25

6.7

4.4

6.72

5.91

mmol/l

50.64

1222

11829

(3037121) Protein [Mass/volume] in Urine

456

1.84

6.16

2.9

3.5

0.18

0.24

g/l

0.94

181

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

3.23

6.16

1.3

1.7

1.61

3.04

u/field

0.92

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

199

1391

1.49

6.11

1.5

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

274

2.08

6.09

1.3

9.58

10.26

u/l

0.15

222

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

128

2.61

6.06

4.3

2.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

3.11

6.05

1.3

1.5

8.50

6.69

u/l

0.25

(3044941) Cell count panel - Synovial fluid

215

2.22

6.04

1.3

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

461

1.82

5.96

1.8

2.7

3.18

2.88

g/l

2.12

418

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

3.55

5.89

2.3

2.6

45152.63

38495.33

ug/l

1.44

(40761539) Cells [Type] in Urine sediment by Light microscopy

5.04

5.87

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

167

2.37

5.85

1.2

1.4

—

(40761511) CBC panel - Blood by Automated count

1437

13715

1.58

5.84

34.1

13.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

232

2.15

5.81

1.6

1.9

7183.88

2489.56

u/l

0.37

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

315

1.97

5.74

1.3

1.5

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

6.89

5.74

1.6

1.16

1.21

mmol/l

0.94

(3016650) Hepatitis A virus Ab [Presence] in Serum

201

2.22

5.69

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

134

2.49

5.55

1.4

4778.56

1568.18

e6/l

0.74

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.92

5.47

5.4

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

386

1.85

5.44

1.5

2.5

35.79

38.08

g/l

2.83

343

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

490

1.75

5.43

1.8

2.6

8.10

7.22

g/l

5.61

446

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.42

5.31

1.5

3.6

49.71

123.83

umol/l

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

457

1.77

5.26

1.7

2.7

10.35

10.29

g/l

0.04

413

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

489

1.74

5.19

1.8

2.6

4.22

3.51

g/l

3.15

446

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

203

2.15

5.16

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

264

2.00

5.16

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

490

1.73

5.16

1.8

2.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

342

1.88

5.15

1.3

1.6

406.40

301.72

mu/l

1.06

310

(3020876) Protein [Mass/time] in 24 hour Urine

133

2.44

5.15

2.0

2.4

0.87

1.60

g/24h

0.70

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

266

2023

1.38

5.13

3.7

2.8

5.29

2.13

e6/l

3.14

155

1089

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

195

2641

0.70

5.07

2.6

3.0

0.59

0.75

ug/l

2.44

126

1712

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

346

1.86

4.98

1.6

2.7

0.00

g/l

-0.00

319

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

369

1.82

4.93

1.7

2.6

0.00

0.03

g/l

1.09

339

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1335

12634

1.39

4.92

30.5

12.6

78.62

80.71

ml/min/173m2

2.21

1175

10479

(3020191) Ethanol [Moles/volume] in Serum or Plasma

100

2.63

4.90

1.5

1.4

1.16

1.14

promille

0.02

(3001019) Free T4 and TSH panel - Serum or Plasma

673

0.45

4.87

1.6

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

349

1.84

4.86

1.6

2.6

0.00

g/l

-0.00

320

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

364

1.82

4.84

2.0

11.06

11.51

mg/l

0.16

335

(3028308) Erythrocytes [#/volume] in Pleural fluid

119

2.46

4.81

1.4

24948.26

86297.68

e6/l

0.56

(3042517) Benzodiazepines panel - Urine

11.48

4.78

5.5

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

3.60

4.77

1.5

1.4

57.20

65.30

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

216

1611

1.40

4.68

5.6

4.4

29.00

32.38

5.86

156

1095

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

288

3609

0.75

4.51

3.6

4.1

20.92

21.43

0.19

104

1719

(1761868) Lipid panel - Serum or Plasma

564

4835

1.26

4.48

3.7

2.8

—

(3048689) Calprotectin [Mass/mass] in Stool

200

1484

1.40

4.46

2.3

2.2

157.74

124.86

ug/g

0.96

155

1196

(3011288) Drugs identified in Urine by Screen method

209

2.04

4.44

3.9

2.6

—

(40768806) Pleura Pathology biopsy report

124

2.36

4.42

1.7

1.6

—

(3044927) Protein electrophoresis panel - Urine

143

2.26

4.42

1.3

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

198

2.05

4.30

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

114

2.39

4.24

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

234

1.95

4.23

2.7

1.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

3.28

4.19

2.9

2.0

67.89

51.28

ug/l

0.43

(3024263) Appearance of Synovial fluid

2.93

4.17

1.1

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

5.27

4.14

1.3

1.2

115.09

61.40

ng/l

—

(40757373) Influenza virus identified in Isolate

4.36

4.13

1.5

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1334

12714

1.33

3.95

4.9

3.9

1.71

1.29

mmol/l

44.14

1165

11655

(3000475) Leukocytes [#/volume] in Synovial fluid

328

1.77

3.94

1.4

1.7

18664.24

14057.87

e6/l

0.40

247

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

460

1.64

3.87

1.4

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

208

1.95

3.79

1.0

1.1

17.62

102.88

iu/ml

1.04

(3045424) Erythrocytes [Presence] in Urine

218

1.90

3.65

1.4

1.3

—

(4281824) Cell count and differential, peritoneal fluid

150

2.09

3.58

1.2

1.1

—

(3022621) pH of Urine by Test strip

117

821

1.46

3.58

4.6

2.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

105

2.31

3.53

2.5

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

193

1.94

3.50

1.9

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

270

2175

1.29

3.48

3.5

2.7

1.49

1.05

e6/l

1.27

158

1237

(21494890) Protein electrophoresis panel - 24 hour Urine

132

2.14

3.46

1.6

2.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

153

2.05

3.42

2.8

2.3

36.33

22.65

mg/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.38

3.32

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

503

1.56

3.32

2.0

2.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.95

3.29

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

109

2.22

3.26

1.4

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

117

838

1.43

3.23

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.42

3.14

1.5

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.52

3.11

3.0

2.3

15.02

18.11

umol/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

180

1.91

3.11

1.2

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

3.45

3.10

1.6

1.3

3.42

3.19

mmol/l

0.14

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.82

3.09

1.7

2.1

4945.00

35540.09

e6/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

139

2.03

3.06

3.2

2.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.69

3.06

1.1

1.2

321.73

222.56

iu/ml

0.32

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

425

1.58

3.05

1.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.02

3.05

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

5.02

3.05

1.3

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

157

1198

1.35

2.98

2.8

2.4

31.57

40.14

u/l

0.99

123

1044

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

10.03

2.98

1.0

1.2

1.60

1.00

u/field

—

(3000764) Benzodiazepines [Presence] in Urine

310

1.67

2.97

3.0

2.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.48

2.96

1.1

1.0

—

(3016879) Cocaine [Presence] in Urine

288

1.69

2.94

3.0

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1024

0.66

2.93

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.26

2.93

1.5

1.1

292.14

297.88

pmol/l

—

(3020650) Glucose [Presence] in Urine

3.45

2.90

1.8

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.71

2.89

1.3

1.6

—

2090600.00

iu/ml

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.44

2.88

1.1

1.06

ratio

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

102

2.17

2.87

1.5

1.2

0.41

0.77

u/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

129

2.03

2.87

3.8

4.1

—

(3048879) Bone marrow aspiration report

3.17

2.85

1.1

2.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.17

2.85

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

144

1.96

2.81

1.2

1.3

23.49

32.34

u/l

0.81

113

(3045788) Cell count panel - Pleural fluid

110

2.11

2.79

1.3

1.5

—

(40761535) Cells panel - Urine sediment

140

1062

1.35

2.78

4.0

3.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

324

1.63

2.77

1.4

—

(3036180) Methadone [Presence] in Urine

3.09

2.77

1.8

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

2.61

2.70

10.5

11.9

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.29

2.68

1.5

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

4.23

2.68

1.1

1.5

—

mmol/l

—

(3027008) Opiates [Presence] in Urine

312

1.62

2.66

3.0

2.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.80

2.65

3.8

2.9

—

(3028300) Cannabinoids [Presence] in Urine

313

1.62

2.63

3.2

2.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.68

2.60

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

579

1.44

2.50

2.1

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

2.12

2.49

2.8

2.0

2.00

2.39

u/field

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.39

2.47

1.0

1.1

111.00

93.69

—

(40768800) Prostate Pathology biopsy report

297

0.43

2.47

1.4

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

657

1.41

2.46

2.0

3.4

32.51

58.07

u/ml

1.46

635

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.82

2.46

1.1

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

1196

11421

1.20

2.44

36.5

16.4

16.27

14.97

11.56

1173

11208

(3011397) Hemoglobin [Presence] in Urine by Test strip

341

2935

1.21

2.40

4.6

3.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.27

2.37

4.0

7.8

—

(40768441) Liver Pathology biopsy report

2.10

2.33

2.1

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.63

2.27

1.2

1.0

—

(3033799) Differential panel - Peritoneal fluid

2.57

2.27

3.1

1.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1390

13500

1.26

2.27

5.9

4.9

2.39

2.80

mmol/l

54.41

1234

12470

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.69

2.20

1.0

1.2

—

(3044007) Cell count panel - Peritoneal fluid

2.69

2.20

3.0

2.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.03

2.16

1.1

—

(3027944) Amphetamines [Presence] in Urine

306

1.55

2.15

3.2

1.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

269

2289

1.21

2.13

1.3

1.2

29.90

29.40

iu/ml

0.03

783

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

354

3090

1.19

2.13

3.0

2.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1447

14140

1.31

2.12

16.3

10.3

28.43

26.36

u/l

2.60

1395

13675

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

197

1625

1.24

2.11

13.7

6.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

160

1968

0.79

2.10

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.08

2.07

1.8

2.1

—

(3002256) Pathology report gross observation

205

1705

1.23

2.04

1.2

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.41

2.02

1.0

1.3

162.67

176.03

mmol/24h

0.23

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.01

2.00

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

163

1.73

1.99

1.3

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

249

1.58

1.96

2.1

1.8

4.62

5.18

mmol/24h

0.31

217

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.25

1.91

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.16

1.88

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.16

1.88

1.1

1.0

—

(3025130) Human papilloma virus identified in Specimen

142

0.35

1.88

1.4

1.9

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.87

1.86

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.40

1.85

2.0

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.21

1.84

1.7

2.4

409.63

1009.76

e6/l

—

(3014891) Appearance of Pleural fluid

3.54

1.84

1.7

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1362

13252

1.21

1.83

5.4

4.4

4.20

4.72

mmol/l

65.40

1206

12315

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.27

1.81

1.0

11.9

73.57

64.95

mg/l

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

193

1.62

1.75

1.1

1.2

5.73

3.43

u/ml

0.21

(3052851) Hemolysis interference index of Serum or Plasma

398

1.42

1.73

5.0

3.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

255

2204

1.19

1.72

1.3

1.2

12.98

12.30

u/ml

0.04

877

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.07

1.70

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

2.07

1.70

1.3

1.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

195

1.60

1.69

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.17

1.66

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

2.59

1.66

1.0

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.90

1.65

1.8

1.4

93.82

79.07

umol/l

0.38

(3051387) C reactive protein [Mass/volume] in Capillary blood

269

1.50

1.64

7.9

3.9

27.81

24.67

mg/l

0.20

169

(4035726) Immunohistochemistry procedure

145

1193

1.24

1.63

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1351

13163

1.19

1.63

5.4

4.4

1.23

1.48

mmol/l

92.72

1192

12150

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.39

1.61

3.8

2.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.88

1.60

2.1

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.01

1.58

1.2

1.3

0.81

1.60

mmol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.70

1.58

1.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

156

0.45

1.55

2.4

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

208

1.55

1.54

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.98

1.54

1.3

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.34

1.52

1.6

2.9

0.80

0.73

u/field

—

(3028717) Thiamine [Mass/volume] in Blood

3.34

1.52

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

392

1.39

1.51

1.7

1.5

0.05

0.10

iu/ml

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.08

1.49

1.8

3.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

194

1.56

1.49

1.1

1.2

3.76

6.49

u/ml

0.77

(3028433) Virus identified in Specimen by Culture

2.44

1.48

1.6

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.44

1.48

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.13

1.44

10.4

5.1

4.66

6.03

mmol/l

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.98

1.43

1.7

2.7

629.23

1348.14

u/ml

1.08

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.26

1.40

1.9

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

120

0.41

1.37

1.6

1.5

—

(3036489) Thrombin time

496

1.32

1.36

1.7

2.0

21.70

21.43

0.12

441

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

376

1.37

1.33

1.3

1.1

—

(3011648) Oxygen content in Venous blood

105

1.72

1.33

3.2

1.9

11.68

10.73

0.41

105

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

144

1.61

1.32

1.1

1.2

104.48

97.74

0.51

137

(3023323) Follitropin [Units/volume] in Serum or Plasma

516

1.31

1.32

1.3

22.32

33.44

iu/l

2.46

443

(3003327) Ova and parasites identified in Stool by Light microscopy

377

1.36

1.31

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

150

0.46

1.31

1.7

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

378

1.36

1.30

1.3

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

116

0.43

1.25

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

445

0.69

1.24

2.3

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

381

1.35

1.24

1.3

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.41

1.24

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

119

0.42

1.24

1.0

1.1

—

(3034426) Prothrombin time (PT)

2.01

1.23

1.0

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

127

1066

1.21

1.22

4.0

2.5

52.41

67.25

ml/min/173m2

3.29

420

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

163

1401

1.18

1.22

3.0

4.2

35.13

21.33

ug/l

0.25

131

1143

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

141

0.49

1.21

1.7

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

141

0.49

1.21

1.7

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

142

0.49

1.21

1.7

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

142

0.49

1.21

1.7

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.11

1.18

1.8

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

111

1.63

1.12

1.3

1.1

—

36.33

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.01

1.12

1.3

1.0

—

(3005033) Fetal Nuchal fold Thickness US

115

0.43

1.12

1.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

112

1.61

1.09

1.3

1.1

—

67.50

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.96

1.09

3.5

2.3

—

(3000330) Specific gravity of Urine by Test strip

614

1.25

1.07

4.2

3.5

—

(3051651) Icteric interference index of Serum or Plasma

1.67

1.04

3.4

4.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

147

0.54

1.04

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.06

1.03

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

122

1.56

1.02

3.4

3.7

57.01

46.56

u/ml

0.16

122

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.00

1.00

1.4

1.2

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

131

1.53

1.00

1.9

2.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.18

0.98

1.6

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

2.18

0.98

1.2

1.9

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.97

0.0

1.0

—

36.06

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.97

0.0

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

124

1.54

0.97

1.6

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.82

0.92

1.1

1.9

23.45

166.84

ug/l

—

(3026470) Cobalt [Mass/volume] in Blood

1.67

0.91

1.6

2.0

2.01

2.86

ug/l

0.71

(3032773) Endomysium IgG Ab [Titer] in Serum

103

0.48

0.89

1.0

1.1

—

(3008898) HLA-B27 [Presence]

438

0.75

0.89

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

298

1.32

0.88

5.0

4.7

—

(3006462) Nitrate [Presence] in Urine

1.86

0.87

2.3

3.0

—

(40768446) Kidney Pathology biopsy report

1.86

0.87

1.4

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

326

1.30

0.85

2.8

2.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

104

1.54

0.84

1.3

1.1

—

2.40

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

388

0.74

0.83

1.3

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

113

0.53

0.83

1.3

1.4

—

(3016228) CD19 cells/100 cells in Blood

1.74

0.82

1.9

1.7

9.63

7.52

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.74

0.82

1.9

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.79

0.0

1.4

—

(3019150) Specific gravity of Urine by Refractometry

297

2744

1.10

0.79

6.0

3.9

1.02

kg/l

0.11

396

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.63

0.78

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

0.76

1.3

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.85

0.73

1.7

2.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.75

0.71

1.3

1.1

122.57

104.89

—

(1002224) Polysomnography panel

536

1.20

0.71

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

145

0.62

0.69

1.3

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

178

1.35

0.69

1.7

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.85

0.68

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.52

0.66

2.8

2.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

127

0.63

0.64

1.3

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

129

0.62

0.64

2.3

2.5

—

(40768795) Lymph node Pathology biopsy report

139

1.37

0.60

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

140

1.36

0.58

3.7

3.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.58

0.0

1.2

—

26.67

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.00

0.58

0.0

1.8

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.72

0.57

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.72

0.57

1.3

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.72

0.57

7.3

7.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.72

0.57

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.72

0.57

1.3

1.1

—

(3017704) Immunofixation for Urine

1.49

0.57

1.3

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.56

1.4

1.3

64.66

250.94

pmol/l

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

124

0.64

0.54

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

195

1.29

0.54

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

694

1.15

0.53

2.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

134

1.35

0.53

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.45

0.53

1.7

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.43

0.53

1.1

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

348

0.80

0.52

2.0

1.7

—

(3042733) HLA Ab [Presence] in Serum

1.50

0.51

2.3

4.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.41

0.51

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

246

0.77

0.49

1.6

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

164

0.73

0.45

3.3

2.0

13.69

13.21

0.99

164

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.40

0.45

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.61

0.43

6.0

7.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

207

1943

1.08

0.43

1.5

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.56

0.42

1.0

2.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

249

1.21

0.41

1.2

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

2.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.3

—

(44813793) Dust mix specific IgE antibody measurement

1.40

0.40

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.40

0.0

5.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.40

0.0

2.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.41

0.39

1.2

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

196

1.23

0.39

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.37

0.38

1.0

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.39

0.38

2.2

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

345

1.16

0.38

1.4

1.2

4.67

8.93

u/ml

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.35

0.38

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.35

0.38

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.35

0.38

1.3

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.36

0.36

1.3

1.5

—

(36660697) Celiac disease serology panel - Serum

104

959

1.09

0.35

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.32

0.33

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.32

0.33

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.32

0.33

1.3

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

136

1.25

0.33

1.2

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

340

1.15

0.33

1.4

1.2

2.66

2.77

u/ml

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

256

1.18

0.33

1.1

1.4

—

11.49

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

866

1.09

0.33

1.2

182.25

146.21

iu/ml

0.19

331

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

252

0.83

0.32

1.1

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.33

0.32

1.3

1.2

18.24

6.77

u/l

0.45

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

433

4467

0.96

0.32

4.1

4.8

2.02

2.67

ug/l

0.81

366

4036

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

334

1.14

0.30

2.1

1.8

31.24

40.50

nmol/l

2.70

322

(3013139) Helicobacter pylori Ag [Presence] in Stool

847

0.92

0.29

1.1

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

223

1.17

0.28

1.5

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.25

0.27

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

1.23

0.27

1.4

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.23

0.27

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

366

1.12

0.27

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

437

0.89

0.27

1.2

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.69

0.26

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

127

0.79

0.25

2.4

5.1

—

49.21

—

(4094501) Cardiovascular stress test using bicycle ergometer

382

0.89

0.25

1.0

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

233

0.86

0.24

1.1

1.2

348.64

280.51

u/ml

0.33

137

(3043410) Blood group antigens tested for on Red Blood Cells

1.28

0.23

3.2

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1.25

0.22

1.2

1.7

11.72

7.67

mmol/l

—

(40768804) Tissue Pathology biopsy report

548

5372

1.03

0.22

2.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

135

1.19

0.21

1.4

1.6

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.16

0.21

1.0

1.3

6.99

9.26

ug/l

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

230

1.13

0.20

1.2

1.4

104.00

131.25

u/ml

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

166

0.84

0.20

1.1

1.0

11.18

2.35

u/ml

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

312

0.90

0.19

1.2

1.4

10.89

27.56

e6/l

0.46

244

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

205

0.88

0.17

1.1

—

11.96

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

505

0.93

0.16

2.1

3.4

1561.31

2841.08

u/ml

0.23

434

(3038177) Helicobacter pylori Ab [Presence] in Serum

204

0.88

0.16

1.4

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

160

1.13

0.14

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

336

0.92

0.14

1.3

1.2

74.78

206.21

miu/ml

—

151

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.82

0.13

1.6

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

190

0.89

0.13

1.5

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.18

0.12

1.7

1.5

—

(4034850) Laboratory test

414

1.06

0.12

25.8

9.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

611

1.05

0.11

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

279

1.08

0.11

1.2

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

134

1.12

0.11

1.0

1.1

2.16

3.05

u/ml

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

144

1.11

0.10

1.0

6.04

2.49

u/ml

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

853

1.03

0.09

1.9

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

957

0.97

0.08

1.9

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

113

0.88

0.08

1.2

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

174

0.92

0.07

1.1

1.0

6.29

4.98

u/ml

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.86

0.07

1.0

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.07

0.07

2.1

6.9

—

(21494434) Karyotype in Bone marrow

132

0.91

0.06

1.0

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

139

1.08

0.05

1.1

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

327

1.04

0.05

2.2

2.1

2.73

5.02

iu/l

2.39

112

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

332

0.96

0.04

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

338

1.04

0.04

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

1467

14654

1.02

0.04

49.1

20.3

40.63

40.25

1.29

1357

13697

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

190

0.95

0.04

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

418

1.03

0.03

2.3

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

161

1.06

0.03

1.1

1.0

2.07

1.72

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

350

0.97

0.03

1.1

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

631

0.98

0.02

1.3

—

(3003694) ABO and Rh group [Type] in Blood

344

3457

0.99

0.02

1.5

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

931

0.99

0.02

3.1

2.2

9.03

13.13

nmol/l

5.69

832

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

198

0.96

0.02

1.1

0.46

2.11

u/ml

—

103

(3010813) Leukocytes [#/volume] in Blood

1466

14670

0.99

0.02

48.6

20.2

7.97

6.60

e9/l

86.08

1431

14256

(40768793) Breast Pathology biopsy report

308

0.97

0.02

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

167

0.96

0.01

1.1

0.51

2.08

u/ml

—

(3000963) Hemoglobin [Mass/volume] in Blood

1467

14676

0.99

0.00

49.2

20.3

132.79

135.88

g/l

9.62

1450

14458

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

102

0.98

0.00

1.0

1.1

269.00

255.34

mg/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

118

1.02

0.00

1.0

0.21

0.27

u/ml

—

(3007461) Platelets [#/volume] in Blood

1467

14666

1.00

0.00

48.6

20.2

254.96

250.17

e9/l

1.94

1440

14295

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

101

0.99

0.00

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

732

1.00

0.00

1.5

—

(3035941) MCH [Entitic mass]

1467

14672

1.00

0.00

48.3

20.1

29.43

30.40

52.42

1450

14455

(3024731) MCV [Entitic volume]

1467

14671

1.00

0.00

48.4

20.1

91.08

91.22

0.45

1450

14457

(3005570) Glucose [Moles/volume] in Urine

143

0.98

0.00

4.7

2.3

—

(3045142) Bone marrow Pathology biopsy report

163

0.98

0.00

1.1

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

1467

14673

1.00

0.00

48.6

20.2

4.56

4.49

e12/l

3.95

1436

14254

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

115

0.96

0.00

1.5

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.91

0.00

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

4.1

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.88

-0.00

1.7

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.89

-0.00

1.8

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

0.06

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.0

—

402.00

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.91

-0.00

1.0

1.3

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

1.7

—

7.99

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

2.18

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.1

—

8.59

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

185.17

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.1

—

37.84

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1745.20

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.91

-0.00

1.0

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

3.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

-0.00

0.0

1.0

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.1

—

23.01

—

(3022475) Manganese [Moles/volume] in Blood

0.00

-0.00

0.0

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_OBESITYXTRMALV and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_OBESITYXTRMALV	4.928 [4.15, 5.85]	< 0.001
Birth year	0.999 [0.99, 1.01]	0.785

During the follow-up period (1.1.1998 — 31.12.2019), 1150 out of 3720 females with E4_OBESITYXTRMALV died.

Males

Parameter	HR [95% CI]	p-value
E4_OBESITYXTRMALV	4.648 [3.91, 5.52]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1186 out of 3284 males with E4_OBESITYXTRMALV died.

Mortality risk

Mortality risk for people of age

years, who have E4_OBESITYXTRMALV.

N-year risk	Females	Males
1	0.708%	0.697%
5	3.189%	4.419%
10	7.568%	11.367%
15	13.934%	20.929%
20	25.508%	33.412%

Relationships between endpoints

↥

Index endpoint: E4_OBESITYXTRMALV – Extreme obesity with alveolar hypoventilation

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Extreme obesity with alveolar hypoventilation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints